メンタルヘルススクリーニングの世界市場予測(~2029):疾患別、スクリーニング別、技術別、年齢別、設定別

■ 英語タイトル:Mental Health Screening Market by Indication (Depression, Bipolar, Schizophrenia, ADHD, Alzheimer, Dementia), Screening (Self, Interview, Observation, Biomarker), Technology (mHealth, Remote Platform, Telehealth), Age, Setting - Global Forecast to 2029

調査会社MarketsandMarkets社が発行したリサーチレポート(データ管理コード:HIT8966-24)■ 発行会社/調査会社:MarketsandMarkets
■ 商品コード:HIT8966-24
■ 発行日:2024年3月
■ 調査対象地域:グローバル
■ 産業分野:医療
■ ページ数:525
■ レポート言語:英語
■ レポート形式:PDF
■ 納品方式:Eメール(受注後24時間以内)
■ 販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥732,600見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥984,200見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥1,206,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能)
MarketsandMarkets社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[メンタルヘルススクリーニングの世界市場予測(~2029):疾患別、スクリーニング別、技術別、年齢別、設定別]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

“メンタルヘルススクリーニング市場は2023年の9億米ドルから2029年には18億米ドルに拡大すると予測され、予測期間中のCAGRは12.2%となる見込み”メンタルヘルス問題に対する意識の高まり、高齢者人口の増加とそれに伴う精神障害の有病率の増加、遠隔モニタリングへの注目の高まりなどが、この市場の成長を促進する要因です。 一方、偏見や限定的な認識、データプライバシーに関する懸念は、予測期間中、メンタルヘルススクリーニングソリューションの採用をある程度阻害する可能性があります。

“技術セグメント別では、AIベースのスクリーニングツールが予測期間に最も高い成長を記録する見込み”
技術に基づいて、メンタルヘルススクリーニング市場は、自己スクリーニングmHealthアプリ、テレヘルス&バーチャルケアソリューション、継続モニタリングウェアラブルデバイス、AIベースのスクリーニングツール、およびリモートメンタルヘルスプラットフォームにセグメント化されます。AIベースのスクリーニングツール分野は、予測期間中に最も高い成長率を目撃すると予測されています。この市場の成長は、AI技術の進歩と相まって、メンタルヘルススクリーニングにおけるスケーラブルで正確なソリューションに対する需要が増加していることに起因しています。

“設定別では臨床設定セグメントが最大のシェアを占めると推定”
設定に基づいて、世界のメンタルヘルススクリーニング市場は、臨床設定、教育機関、職場/企業プログラム、オンラインプラットフォーム、およびその他の設定にセグメント化されます。2022年のメンタルヘルススクリーニング市場で最大のシェアを占めたのは、臨床環境セグメントでした。このセグメントは、認知度の向上、メンタルヘルス障害の有病率の上昇、技術の進歩、政策支援、予防および患者中心のケアへのシフトにより、大きな成長が見込まれています。

“高齢者(65歳以上)セグメントは、年齢層別で予測期間に最も高い成長を記録する見込み”
年齢層に基づき、メンタルヘルススクリーニング市場は小児・青年(0~18歳)、成人(19~64歳)、シニア(65歳以上)に区分されます。シニア層は予測期間中に最も高い成長率を示すと予測されています。シニア層におけるメンタルヘルス検査ソリューションの普及は、高齢者人口の増加と、それに伴う認知症、アルツハイマー病、後期うつ病などの加齢関連疾患の増加が原動力となっています。

“予測期間中、メンタルヘルススクリーニング市場で最も高い成長を記録するアジア太平洋地域”
世界のメンタルヘルススクリーニング市場は、北米、欧州、アジア太平洋地域、その他の地域の4つの主要地域に区分されます。2022年の予測期間では、アジア太平洋地域がメンタルヘルススクリーニングソリューションにおいて最も高い成長を記録する見込みです。患者負担の増加、精神障害の罹患率の増加によるメンタルヘルスサービスの利用しやすさの向上、精神障害に関する認識を高めるための政府のイニシアチブの高まりなどの要因が、アジア太平洋地域におけるメンタルヘルススクリーニング市場の成長を促進すると予想されます。

供給側、需要側、企業タイプ別、呼称別、地域別の一次インタビューの内訳:
- 供給サイド別 ティア1(25%)、ティア2(5%)、ティア3(70%)
- 役職別 Cレベルエグゼクティブ(27%)、ディレクターレベル(18%)、マネージャー(55%)
- 地域別 北米 (45%)、欧州 (30%)、アジア太平洋 (20%)、中南米 (3%)、中東・アフリカ (2%)

メンタルヘルススクリーニング市場の主要企業は、Adaptive Testing Technologies(米国)、Proem Behavioral Health(米国)、Aiberry(米国)、SonderMind Inc.(米国)、Clarigent Health(米国)、Riverside Community Care(米国)、Kintsugi Mindful Wellness, Inc.(米国)、Thymia Limited(英国)、Ellipsis Health Inc.(米国)、Canary Speech, Inc. (米国)、Headspace Health社(米国)、Quartet Health社(米国)、Modern Life社(米国)、Sonde Health社(米国)、FuturesTHRIVE社(米国)、Koninklijke Philips N.V.(オランダ)、Alphabet Inc. (Fitbit)(米国)、ResMed(米国)、Apple Inc.(米国)、MoodFit(米国)、Wellin5 USA Inc.(カナダ)、MoodTools(米国)、Cognitive Health Solutions LLC(米国)、Woebot Labs Inc.(米国)、CogniABle(インド)などです。プレーヤーは、提供する製品を増やし、顧客の満たされていないニーズに対応し、収益性を高め、世界市場でのプレゼンスを拡大するために、パートナーシップ、買収、製品発表などの有機的および無機的な成長戦略を採用しました。

調査範囲
- 本レポートでは、メンタルヘルススクリーニング市場を用途、検診方法、技術、年齢層、環境、地域別に調査しています。
- 市場成長に影響を与える要因(促進要因、阻害要因、機会、課題など)を分析します。
- 利害関係者向けに市場の機会と課題を評価し、市場リーダー向けに競争環境の詳細を提供します。
- 本レポートでは、メンタルヘルススクリーニング市場の成長動向、展望、市場全体への貢献に関してミクロ市場を調査しています。
- 主要5地域に関して、市場セグメントの収益を予測しています。

レポート購入の理由
本レポートは、既存企業だけでなく、新規参入企業や小規模企業が市場の動向を把握するのに役立ち、ひいては、より大きなシェアを獲得するのに役立ちます。本レポートを購入される企業は、以下の5つの戦略を1つまたは組み合わせて使用することができます。

本レポートは、以下のポイントに関する洞察を提供します:
 主な推進要因(高齢者人口の増加とそれに伴う精神障害の有病率の増加、メンタルヘルス問題に対する意識の高まり、技術の進歩、遠隔モニタリングへの注目の高まり)、阻害要因(スティグマと限られた意識、データプライバシーへの懸念)、機会(ウェアラブル技術との統合、ソーシャルメディアの台頭とメンタルヘルススクリーニングツールの採用への影響)、課題(ウェアラブル技術との統合)の分析。
 製品開発/イノベーション: メンタルヘルススクリーニング市場における今後の技術、研究開発活動、製品発売に関する詳細な洞察。
 市場開発: 有利な新興市場に関する包括的情報。本レポートでは、地域別にさまざまなタイプのメンタルヘルス検査ソリューションの市場を分析しています。
 市場の多様化: メンタルヘルススクリーニング市場におけるソリューション、未開拓地域、最新動向、投資に関する情報を網羅。
 競合評価: メンタルヘルススクリーニング市場における主要企業の市場シェア、戦略、製品、流通ネットワーク、製造能力を詳細に評価します。

1 はじめに
2 調査方法
3 エグゼクティブサマリー
4 プレミアムインサイト
5 市場概要
6 メンタルヘルススクリーニング市場:用途別
7 メンタルヘルススクリーニング市場:スクリーニング方法別
8 メンタルヘルススクリーニング市場:技術別
9 メンタルヘルススクリーニング市場:年齢層別
10 メンタルヘルススクリーニング市場:設定別
11 メンタルヘルススクリーニング市場:地域別
12 競争状況
13 企業プロファイル
14 付録

*** レポート目次(コンテンツ)***

1 INTRODUCTION 71
1.1 STUDY OBJECTIVES 71
1.2 MARKET DEFINITION 71
1.2.1 INCLUSIONS & EXCLUSIONS 72
1.3 MARKET SCOPE 73
1.3.1 MARKET SEGMENTATION 73
FIGURE 1 MENTAL HEALTH SCREENING MARKET SEGMENTATION 73
1.3.2 REGIONAL SEGMENTATION 74
FIGURE 2 MENTAL HEALTH SCREENING MARKET: REGIONAL SEGMENTATION 74
1.3.3 YEARS CONSIDERED 74
1.4 STAKEHOLDERS 75
1.5 CURRENCY CONSIDERED 75
2 RESEARCH METHODOLOGY 76
2.1 RESEARCH DATA 76
2.2 RESEARCH APPROACH 76
FIGURE 3 RESEARCH APPROACH 76
2.2.1 SECONDARY DATA 77
2.2.1.1 Key data from secondary sources 77
2.2.2 PRIMARY DATA 78
FIGURE 4 PRIMARY SOURCES 78
2.2.2.1 Key data from primary sources 79
2.2.2.2 Key industry insights 80
2.2.2.3 Breakdown of primaries 80
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 80
2.3 MARKET SIZE ESTIMATION 81
FIGURE 6 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 81
FIGURE 7 MENTAL HEALTH SCREENING MARKET: REVENUE SHARE ANALYSIS ILLUSTRATION FOR KONINKLIJKE PHILIPS 82
FIGURE 8 CAGR PROJECTIONS 84
FIGURE 9 IMPACT ON MARKET GROWTH AND CAGR: ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2023–2029) 85
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 86
FIGURE 10 DATA TRIANGULATION METHODOLOGY 86
2.5 MARKET SHARE ESTIMATION 87
2.6 STUDY ASSUMPTIONS 87
2.7 LIMITATIONS 87
2.7.1 METHODOLOGY-RELATED LIMITATIONS 87
2.7.2 SCOPE-RELATED LIMITATIONS 88
2.8 RISK ASSESSMENT 88
TABLE 1 RISK ASSESSMENT: MENTAL HEALTH SCREENING MARKET 88
2.9 IMPACT OF RECESSION ON MENTAL HEALTH SCREENING MARKET 88
3 EXECUTIVE SUMMARY 89
FIGURE 11 MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2023 VS. 2029 (USD MILLION) 89
FIGURE 12 MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2023 VS. 2029 (USD MILLION) 90
FIGURE 13 MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2022 VS. 2027 (USD MILLION) 90
FIGURE 14 MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2023 VS. 2029 (USD MILLION) 91
FIGURE 15 MENTAL HEALTH SCREENING MARKET, BY SETTING, 2023 VS. 2029 (USD MILLION) 92
FIGURE 16 GEOGRAPHICAL SNAPSHOT OF MENTAL HEALTH SCREENING MARKET 93
4 PREMIUM INSIGHTS 94
4.1 MENTAL HEALTH SCREENING MARKET OVERVIEW 94
FIGURE 17 GROWING INCIDENCE OF MENTAL HEALTH DISORDERS TO DRIVE MARKET 94
4.2 ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET, BY APPLICATION AND COUNTRY (2022) 95
FIGURE 18 PHYSIOLOGICAL DISORDERS ACCOUNTED FOR LARGEST SHARE OF MENTAL HEALTH SCREENING MARKET IN 2022 95
4.3 MENTAL HEALTH SCREENING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 96
FIGURE 19 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 96
4.4 MENTAL HEALTH SCREENING MARKET, BY REGION (2020−2027) 97
FIGURE 20 NORTH AMERICA TO CONTINUE TO DOMINATE MARKET DURING FORECAST PERIOD 97
4.5 MENTAL HEALTH SCREENING MARKET: DEVELOPED VS. EMERGING ECONOMIES 97
FIGURE 21 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD 97
5 MARKET OVERVIEW 98
5.1 INTRODUCTION 98
5.2 MARKET DYNAMICS 98
FIGURE 22 MENTAL HEALTH SCREENING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 98
5.2.1 DRIVERS 99
5.2.1.1 Growing geriatric population and subsequent increase in prevalence of mental disorders 99
5.2.1.2 Rising awareness of mental health issues 99
5.2.1.3 Technological advancements 100
5.2.1.4 Increasing focus on remote monitoring 101
5.2.2 RESTRAINTS 101
5.2.2.1 Stigma and limited awareness 101
5.2.2.2 Data privacy concerns 102
5.2.3 OPPORTUNITIES 103
5.2.3.1 Integration with wearable technologies 103
5.2.3.2 Rise of social media and its impact on adoption of mental health screening tools 103
5.2.4 CHALLENGES 104
5.2.4.1 Concerns regarding accuracy and validity 104
5.3 KEY INDUSTRY TRENDS 104
5.3.1 INTEGRATION WITH PRIMARY CARE SETTINGS 104
5.3.2 DIGITAL AND REMOTE SOLUTIONS 105
5.4 PRICING ANALYSIS 106
TABLE 2 AVERAGE SELLING PRICE TREND, BY REGION 106
TABLE 3 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY TECHNOLOGY 106
5.5 VALUE/SUPPLY CHAIN ANALYSIS 107
5.5.1 RESEARCH & DEVELOPMENT 107
5.5.2 MANUFACTURING & PRODUCTION 107
5.5.3 DISTRIBUTION 107
5.5.4 MARKETING & SALES 107
5.5.5 POST-SALES SERVICES 107
FIGURE 23 MENTAL HEALTH SCREENING MARKET: VALUE CHAIN ANALYSIS 108
5.6 ECOSYSTEM ANALYSIS 108
5.7 PORTER’S FIVE FORCES ANALYSIS 109
TABLE 4 PORTER’S FIVE FORCES ANALYSIS: MENTAL HEALTH SCREENING MARKET 109
5.7.1 INTENSITY OF COMPETITIVE RIVALRY 110
5.7.2 BARGAINING POWER OF SUPPLIERS 110
5.7.3 BARGAINING POWER OF BUYERS 110
5.7.4 THREAT OF NEW ENTRANTS 110
5.7.5 THREAT OF SUBSTITUTES 110
5.8 REGULATORY LANDSCAPE 111
5.8.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 111
TABLE 5 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 111
5.8.2 REGULATORY ANALYSIS 112
5.8.2.1 North America 112
5.8.2.2 Europe 112
5.8.2.3 Asia Pacific 113
5.8.2.4 Latin America 113
5.8.2.5 Middle East & Africa 113
5.9 TECHNOLOGY ANALYSIS 114
5.9.1 KEY TECHNOLOGIES 114
5.9.1.1 Artificial Intelligence (AI) & Machine Learning (ML) 114
5.9.1.2 Telehealth platforms 114
5.9.1.3 Mobile apps and platforms 114
5.9.2 COMPLEMENTARY TECHNOLOGIES 114
5.9.2.1 Electronic Health Records (EHRs) 114
5.9.2.2 Chatbots and virtual assistants 114
5.9.3 ADJACENT TECHNOLOGIES 115
5.9.3.1 Genetic and biological markers 115
5.10 PATENT ANALYSIS 115
5.10.1 PATENT PUBLICATION TRENDS FOR MENTAL HEALTH SCREENING 115
5.10.2 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES 115
FIGURE 24 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR MENTAL HEALTH SCREENING PATENTS, 2012–2023 115
5.10.3 MAJOR PATENTS IN MENTAL HEALTH SCREENING MARKET 116
FIGURE 25 MAJOR PATENTS FOR MENTAL HEALTH SCREENING SOLUTIONS (2012–2023) 116
5.10.4 PATENTS FILED 117
5.11 TRADE ANALYSIS 119
FIGURE 26 PRODUCT EXPORTS UNDER HSN CODE: 9113, BY COUNTRY, 2022 (USD THOUSAND) 120
FIGURE 27 PRODUCT IMPORTS UNDER HSN CODE 9113, BY COUNTRY, 2022 (USD THOUSAND) 120
5.12 CASE STUDY ANALYSIS 121
TABLE 6 CASE STUDY 1: AIBERRY’S COLLABORATIVE CLINICAL STUDY WITH UNIVERSITY OF ARIZONA FOR AI-POWERED MENTAL HEALTH SCREENING PLATFORM 121
TABLE 7 CASE STUDY 2: IMPACT OF MINDWISE SCREENING PROGRAM AT HARVARD UNIVERSITY 121
5.13 KEY CONFERENCES & EVENTS, 2024–2025 122
5.13.1 LIST OF KEY CONFERENCES & EVENTS IN MENTAL HEALTH SCREENING MARKET, 2024–2025 122
5.14 KEY STAKEHOLDERS & BUYING CRITERIA 124
5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS 124
TABLE 8 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MENTAL HEALTH SCREENING SOLUTIONS 124
TABLE 9 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS IN MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY 125
5.14.2 BUYING CRITERIA 125
FIGURE 28 KEY BUYING CRITERIA FOR MENTAL HEALTH SCREENING SOLUTIONS, BY TECHNOLOGY 125
TABLE 10 KEY BUYING CRITERIA FOR MENTAL HEALTH SCREENING SOLUTIONS, BY TECHNOLOGY 125
5.15 UNMET NEEDS 126
TABLE 11 UNMET NEEDS IN MENTAL HEALTH SCREENING MARKET 126
5.15.1 END-USER EXPECTATIONS 127
TABLE 12 END-USER EXPECTATIONS IN MENTAL HEALTH SCREENING MARKET 127

5.16 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 128
FIGURE 29 REVENUE SHIFTS AND NEW REVENUE POCKETS FOR MENTAL HEALTH SCREENING MARKET 128
5.17 REIMBURSEMENT SCENARIO ANALYSIS 128
TABLE 13 CPT CODES AND REIMBURSEMENT ANALYSIS IN MENTAL HEALTH SCREENING MARKET IN US 129
5.18 BUSINESS MODEL ANALYSIS 129
5.19 INVESTMENT & FUNDING SCENARIO 130
FIGURE 30 INVESTOR DEALS AND VC FUNDING OF US-BASED MENTAL HEALTH STARTUPS INCREASED IN 2020 130
6 MENTAL HEALTH SCREENING MARKET, BY APPLICATION 131
6.1 INTRODUCTION 132
TABLE 14 MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2018–2021 (USD MILLION) 132
TABLE 15 MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 133
6.2 PHYSIOLOGICAL DISORDERS 133
TABLE 16 MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 133
TABLE 17 MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 134
TABLE 18 MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY COUNTRY, 2018–2021 (USD MILLION) 134
TABLE 19 MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY COUNTRY, 2022–2029 (USD MILLION) 135
6.2.1 DEPRESSION 135
6.2.1.1 Increased adoption of depression screening to drive market 135
TABLE 20 MENTAL HEALTH SCREENING MARKET FOR DEPRESSION, BY COUNTRY, 2018–2021 (USD MILLION) 137
TABLE 21 MENTAL HEALTH SCREENING MARKET FOR DEPRESSION, BY COUNTRY, 2022–2029 (USD MILLION) 138
6.2.2 ANXIETY 138
6.2.2.1 Increasing burden of anxiety disorders & rising awareness to fuel market growth 138
TABLE 22 MENTAL HEALTH SCREENING MARKET FOR ANXIETY, BY COUNTRY, 2018–2021 (USD MILLION) 140
TABLE 23 MENTAL HEALTH SCREENING MARKET FOR ANXIETY, BY COUNTRY, 2022–2029 (USD MILLION) 141
6.2.3 POST-TRAUMATIC STRESS DISORDER (PTSD) 141
6.2.3.1 Rising number of initiatives for PTSD to propel market 141
TABLE 24 MENTAL HEALTH SCREENING MARKET FOR POST-TRAUMATIC STRESS DISORDER (PTSD), BY COUNTRY, 2018–2021 (USD MILLION) 142
TABLE 25 MENTAL HEALTH SCREENING MARKET FOR POST-TRAUMATIC STRESS DISORDER (PTSD), BY COUNTRY, 2022–2029 (USD MILLION) 143
6.2.4 BIPOLAR DISORDER 143
6.2.4.1 Growing public awareness to drive bipolar disorder screening uptake 143
TABLE 26 MENTAL HEALTH SCREENING MARKET FOR BIPOLAR DISORDER, BY COUNTRY, 2018–2021 (USD MILLION) 144
TABLE 27 MENTAL HEALTH SCREENING MARKET FOR BIPOLAR DISORDER, BY COUNTRY, 2022–2029 (USD MILLION) 145
6.2.5 EATING DISORDER 145
6.2.5.1 Increasing incidence and hospital visits to drive adoption of eating disorder screening 145
FIGURE 31 GLOBAL EATING DISORDER PREVALENCE, BY AGE, 2015–2019 146
TABLE 28 MENTAL HEALTH SCREENING MARKET FOR EATING DISORDER, BY COUNTRY, 2018–2021 (USD MILLION) 147
TABLE 29 MENTAL HEALTH SCREENING MARKET FOR EATING DISORDER, BY COUNTRY, 2022–2029 (USD MILLION) 147
6.2.6 SUBSTANCE USE 148
6.2.6.1 Increasing cases of substance use to drive market 148
TABLE 30 MENTAL HEALTH SCREENING MARKET FOR SUBSTANCE USE, BY COUNTRY, 2018–2021 (USD MILLION) 149
TABLE 31 MENTAL HEALTH SCREENING MARKET FOR SUBSTANCE USE, BY COUNTRY, 2022–2029 (USD MILLION) 150
6.2.7 OTHER PHYSIOLOGICAL DISORDERS 150
TABLE 32 MENTAL HEALTH SCREENING MARKET FOR OTHER PHYSIOLOGICAL DISORDERS, BY COUNTRY, 2018–2021 (USD MILLION) 151
TABLE 33 MENTAL HEALTH SCREENING MARKET FOR OTHER PHYSIOLOGICAL DISORDERS, BY COUNTRY, 2022–2029 (USD MILLION) 151
6.3 PSYCHIATRIC DISORDERS 152
TABLE 34 MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 152
TABLE 35 MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 152
TABLE 36 MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY COUNTRY, 2018–2021 (USD MILLION) 153
TABLE 37 MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY COUNTRY, 2022–2029 (USD MILLION) 153
6.3.1 SCHIZOPHRENIA 154
6.3.1.1 Advancements in screening tools for schizophrenia to support growth 154
TABLE 38 MENTAL HEALTH SCREENING MARKET FOR SCHIZOPHRENIA, BY COUNTRY, 2018–2021 (USD MILLION) 155
TABLE 39 MENTAL HEALTH SCREENING MARKET FOR SCHIZOPHRENIA, BY COUNTRY, 2022–2029 (USD MILLION) 155
6.3.2 PSYCHOTIC DISORDER 156
6.3.2.1 Increasing need for screening tools for early detection to drive market growth 156
TABLE 40 MENTAL HEALTH SCREENING MARKET FOR PSYCHOTIC DISORDER, BY COUNTRY, 2018–2021 (USD MILLION) 156
TABLE 41 MENTAL HEALTH SCREENING MARKET FOR PSYCHOTIC DISORDER,
BY COUNTRY, 2022–2029 (USD MILLION) 157
6.3.3 DISSOCIATIVE DISORDER 157
6.3.3.1 Growing awareness and education through screening and content creation to favor market growth 157
TABLE 42 MENTAL HEALTH SCREENING MARKET FOR DISSOCIATIVE DISORDER, BY COUNTRY, 2018–2021 (USD MILLION) 158
TABLE 43 MENTAL HEALTH SCREENING MARKET FOR DISSOCIATIVE DISORDER, BY COUNTRY, 2022–2029 (USD MILLION) 159
6.3.4 OBSESSIVE COMPULSIVE DISORDER (OCD) 159
6.3.4.1 Advancements in assessment tools to support market growth 159
TABLE 44 MENTAL HEALTH SCREENING MARKET FOR OBSESSIVE COMPULSIVE DISORDER (OCD), BY COUNTRY, 2018–2021 (USD MILLION) 160
TABLE 45 MENTAL HEALTH SCREENING MARKET FOR OBSESSIVE COMPULSIVE DISORDER (OCD), BY COUNTRY, 2022–2029 (USD MILLION) 160
6.3.5 ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) 161
6.3.5.1 Increasing cases & diagnosis to contribute to increased demand for ADHD screening 161
TABLE 46 MENTAL HEALTH SCREENING MARKET FOR ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD), BY COUNTRY, 2018–2021 (USD MILLION) 161
TABLE 47 MENTAL HEALTH SCREENING MARKET FOR ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD), BY COUNTRY, 2022–2029 (USD MILLION) 162
6.3.6 OTHER PSYCHIATRIC DISORDERS 162
TABLE 48 MENTAL HEALTH SCREENING MARKET FOR OTHER PSYCHIATRIC DISORDERS, BY COUNTRY, 2018–2021 (USD MILLION) 163
TABLE 49 MENTAL HEALTH SCREENING MARKET FOR OTHER PSYCHIATRIC DISORDERS, BY COUNTRY, 2022–2029 (USD MILLION) 163
6.4 BEHAVIORAL DISORDERS 164
TABLE 50 MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS,
BY TYPE, 2018–2021 (USD MILLION) 164
TABLE 51 MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS,
BY TYPE, 2022–2029 (USD MILLION) 164
TABLE 52 MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS,
BY COUNTRY, 2018–2021 (USD MILLION) 165
TABLE 53 MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS,
BY COUNTRY, 2022–2029 (USD MILLION) 165
6.4.1 SELF-HARM 166
6.4.1.1 Advancements in screening technologies to drive awareness and growth in self-harm screening market 166
TABLE 54 MENTAL HEALTH SCREENING MARKET FOR SELF-HARM DISORDERS, BY COUNTRY, 2018–2021 (USD MILLION) 166
TABLE 55 MENTAL HEALTH SCREENING MARKET FOR SELF-HARM DISORDERS, BY COUNTRY, 2022–2029 (USD MILLION) 167
6.4.2 AGGRESSION 167
6.4.2.1 Rising cases of workplace aggression to propel demand for aggression screening 167
TABLE 56 MENTAL HEALTH SCREENING MARKET FOR AGGRESSION DISORDERS, BY COUNTRY, 2018–2021 (USD MILLION) 168
TABLE 57 MENTAL HEALTH SCREENING MARKET FOR AGGRESSION DISORDERS, BY COUNTRY, 2022–2029 (USD MILLION) 168
6.4.3 SLEEP DISORDERS 169
6.4.3.1 Increased stress and unhealthy lifestyles among adults to drive market 169
TABLE 58 MENTAL HEALTH SCREENING MARKET FOR SLEEP DISORDERS, BY COUNTRY, 2018–2021 (USD MILLION) 170
TABLE 59 MENTAL HEALTH SCREENING MARKET FOR SLEEP DISORDERS, BY COUNTRY, 2022–2029 (USD MILLION) 170
6.4.4 SOCIAL WITHDRAWAL 171
6.4.4.1 Increasing adolescent loneliness to drive demand for social withdrawal screening 171
TABLE 60 MENTAL HEALTH SCREENING MARKET FOR SOCIAL WITHDRAWAL DISORDERS, BY COUNTRY, 2018–2021 (USD MILLION) 172
TABLE 61 MENTAL HEALTH SCREENING MARKET FOR SOCIAL WITHDRAWAL DISORDERS, BY COUNTRY, 2022–2029 (USD MILLION) 172
6.4.5 HYPERACTIVITY 173
6.4.5.1 Increased awareness and recognition to drive growth 173
TABLE 62 MENTAL HEALTH SCREENING MARKET FOR HYPERACTIVITY DISORDERS, BY COUNTRY, 2018–2021 (USD MILLION) 173
TABLE 63 MENTAL HEALTH SCREENING MARKET FOR HYPERACTIVITY DISORDERS, BY COUNTRY, 2022–2029 (USD MILLION) 174
6.4.6 OTHER BEHAVIORAL DISORDERS 174
TABLE 64 MENTAL HEALTH SCREENING MARKET FOR OTHER BEHAVIORAL DISORDERS, BY COUNTRY, 2018–2021 (USD MILLION) 175
TABLE 65 MENTAL HEALTH SCREENING MARKET FOR OTHER BEHAVIORAL DISORDERS, BY COUNTRY, 2022–2029 (USD MILLION) 175
6.5 COGNITIVE DISORDERS 176
TABLE 66 MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 176
TABLE 67 MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 176
TABLE 68 MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY COUNTRY, 2018–2021 (USD MILLION) 177
TABLE 69 MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY COUNTRY, 2022–2029 (USD MILLION) 178
6.5.1 COGNITIVE IMPAIRMENT 178
6.5.1.1 Growing geriatric population and rising incidence of neurodegenerative disorders to support market growth 178
TABLE 70 MENTAL HEALTH SCREENING MARKET FOR COGNITIVE IMPAIRMENT, BY COUNTRY, 2018–2021 (USD MILLION) 179
TABLE 71 MENTAL HEALTH SCREENING MARKET FOR COGNITIVE IMPAIRMENT, BY COUNTRY, 2022–2029 (USD MILLION) 180
6.5.2 DEMENTIA 180
6.5.2.1 Rising initiatives to promote dementia screening awareness to fuel market 180
TABLE 72 MENTAL HEALTH SCREENING MARKET FOR DEMENTIA, BY COUNTRY, 2018–2021 (USD MILLION) 181
TABLE 73 MENTAL HEALTH SCREENING MARKET FOR DEMENTIA FOR, BY COUNTRY, 2022–2029 (USD MILLION) 182
6.5.3 ALZHEIMER’S DISEASE 182
6.5.3.1 Favorable initiatives and increased access to screening to drive market 182
TABLE 74 MENTAL HEALTH SCREENING MARKET FOR ALZHEIMER’S DISEASE, BY COUNTRY, 2018–2021 (USD MILLION) 183
TABLE 75 MENTAL HEALTH SCREENING MARKET FOR ALZHEIMER’S DISEASE, BY COUNTRY, 2022–2029 (USD MILLION) 184
6.5.4 OTHER COGNITIVE DISORDERS 184
TABLE 76 MENTAL HEALTH SCREENING MARKET FOR OTHER COGNITIVE DISORDERS, BY COUNTRY, 2018–2021 (USD MILLION) 185
TABLE 77 MENTAL HEALTH SCREENING MARKET FOR OTHER COGNITIVE DISORDERS, BY COUNTRY, 2022–2029 (USD MILLION) 185
7 MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD 186
7.1 INTRODUCTION 187
TABLE 78 MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2018–2021 (USD MILLION) 187
TABLE 79 MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2022–2029 (USD MILLION) 187
7.2 SELF-REPORTED QUESTIONNAIRES & SURVEYS 188
TABLE 80 MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2018–2021 (USD MILLION) 188
TABLE 81 MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2022–2029 (USD MILLION) 189
TABLE 82 MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY COUNTRY, 2018–2021 (USD MILLION) 189
TABLE 83 MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY COUNTRY, 2022–2029 (USD MILLION) 190
7.2.1 BECK DEPRESSION INVENTORY (BDI) 190
7.2.1.1 Increasing prevalence of depression to drive demand for BDI 190
TABLE 84 MENTAL HEALTH SCREENING MARKET FOR BECK DEPRESSION INVENTORY (BDI), BY COUNTRY, 2018–2021 (USD MILLION) 191
TABLE 85 MENTAL HEALTH SCREENING MARKET FOR BECK DEPRESSION INVENTORY (BDI), BY COUNTRY, 2022–2029 (USD MILLION) 192
7.2.2 GENERALIZED ANXIETY DISORDER-7 (GAD-7) 192
7.2.2.1 Growing concerns regarding anxiety disorders in adults to boost market 192
TABLE 86 MENTAL HEALTH SCREENING MARKET FOR GENERALIZED ANXIETY DISORDER-7 (GAD-7), BY COUNTRY, 2018–2021 (USD MILLION) 193
TABLE 87 MENTAL HEALTH SCREENING MARKET FOR GENERALIZED ANXIETY DISORDER-7 (GAD-7), BY COUNTRY, 2022–2029 (USD MILLION) 194
7.2.3 HAMILTON ANXIETY RATING SCALE (HAM-A) 194
7.2.3.1 Increasing demand for standardized & reliable assessment tools to favor market growth 194
TABLE 88 MENTAL HEALTH SCREENING MARKET FOR HAMILTON ANXIETY RATING SCALE (HAM-A), BY COUNTRY, 2018–2021 (USD MILLION) 195
TABLE 89 MENTAL HEALTH SCREENING MARKET FOR HAMILTON ANXIETY RATING SCALE (HAM-A), BY COUNTRY, 2022–2029 (USD MILLION) 196
7.2.4 PATIENT HEALTH QUESTIONNAIRE-12 (PHQ-12) 196
7.2.4.1 Growing focus on early intervention to boost demand 196
TABLE 90 MENTAL HEALTH SCREENING MARKET FOR PATIENT HEALTH QUESTIONNAIRE-12 (PHQ-12), BY COUNTRY, 2018–2021 (USD MILLION) 197
TABLE 91 MENTAL HEALTH SCREENING MARKET FOR PATIENT HEALTH QUESTIONNAIRE-12 (PHQ-12), BY COUNTRY, 2022–2029 (USD MILLION) 198
7.2.5 YALE-BROWN OBSESSIVE COMPULSIVE SCALE (Y-BOCS) 198
7.2.5.1 Rising awareness of obsessive compulsive disorder (OCD) to fuel growth 198
TABLE 92 MENTAL HEALTH SCREENING MARKET FOR YALE-BROWN OBSESSIVE COMPULSIVE SCALE (Y-BOCS), BY COUNTRY, 2018–2021 (USD MILLION) 199
TABLE 93 MENTAL HEALTH SCREENING MARKET FOR YALE-BROWN OBSESSIVE COMPULSIVE SCALE (Y-BOCS), BY COUNTRY, 2022–2029 (USD MILLION) 200
7.2.6 OTHER SELF-REPORTED QUESTIONNAIRES & SURVEYS 200
TABLE 94 MENTAL HEALTH SCREENING MARKET FOR OTHER SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY COUNTRY, 2018–2021 (USD MILLION) 201
TABLE 95 MENTAL HEALTH SCREENING MARKET FOR OTHER SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY COUNTRY, 2022–2029 (USD MILLION) 202
7.3 CLINICAL INTERVIEWS 202
TABLE 96 MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2018–2021 (USD MILLION) 203
TABLE 97 MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2022–2029 (USD MILLION) 203
TABLE 98 MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY COUNTRY, 2018–2021 (USD MILLION) 204
TABLE 99 MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY COUNTRY, 2022–2029 (USD MILLION) 205
7.3.1 MINI INTERNATIONAL NEUROPSYCHIATRIC INTERVIEW (MINI) 205
7.3.1.1 Increasing global burden of psychiatric disorders to boost market growth 205
TABLE 100 MENTAL HEALTH SCREENING MARKET FOR MINI INTERNATIONAL NEUROPSYCHIATRIC INTERVIEW (MINI), BY COUNTRY, 2018–2021 (USD MILLION) 206
TABLE 101 MENTAL HEALTH SCREENING MARKET FOR MINI INTERNATIONAL NEUROPSYCHIATRIC INTERVIEW (MINI), BY COUNTRY, 2022–2029 (USD MILLION) 207
7.3.2 STRUCTURED CLINICAL INTERVIEWS FOR DSM (SCID) 207
7.3.2.1 Growing demand for comprehensive & detail assessment screening methods to favor market growth 207
TABLE 102 MENTAL HEALTH SCREENING MARKET FOR STRUCTURED CLINICAL INTERVIEWS FOR DSM (SCID), BY COUNTRY, 2018–2021 (USD MILLION) 208
TABLE 103 MENTAL HEALTH SCREENING MARKET FOR STRUCTURED CLINICAL INTERVIEWS FOR DSM (SCID), BY COUNTRY, 2022–2029 (USD MILLION) 209
7.3.3 DIAGNOSTIC INTERVIEW FOR PSYCHOLOGICAL DISTRESS (DIPD) 209
7.3.3.1 Increasing prevalence of psychological distress post pandemic to drive demand for DIPD 209
TABLE 104 MENTAL HEALTH SCREENING MARKET FOR DIAGNOSTIC INTERVIEW FOR PSYCHOLOGICAL DISTRESS (DIPD), BY COUNTRY, 2018–2021 (USD MILLION) 210
TABLE 105 MENTAL HEALTH SCREENING MARKET FOR DIAGNOSTIC INTERVIEW FOR PSYCHOLOGICAL DISTRESS (DIPD), BY COUNTRY, 2022–2029 (USD MILLION) 211
7.3.4 OTHER CLINICAL INTERVIEWS 211
TABLE 106 MENTAL HEALTH SCREENING MARKET FOR OTHER CLINICAL INTERVIEWS, BY COUNTRY, 2018–2021 (USD MILLION) 212
TABLE 107 MENTAL HEALTH SCREENING MARKET FOR OTHER CLINICAL INTERVIEWS, BY COUNTRY, 2022–2029 (USD MILLION) 213
7.4 OBSERVATION-BASED ASSESSMENTS 213
7.4.1 ADVANCES IN WEARABLE TECHNOLOGIES TO REVOLUTIONIZE OBSERVATION-BASED ASSESSMENT TOOLS 213
TABLE 108 MENTAL HEALTH SCREENING MARKET FOR OBSERVATION-BASED ASSESSMENTS, BY COUNTRY, 2018–2021 (USD MILLION) 214
TABLE 109 MENTAL HEALTH SCREENING MARKET FOR OBSERVATION-BASED ASSESSMENTS, BY COUNTRY, 2022–2029 (USD MILLION) 215
7.5 BIOMARKER TESTING 215
7.5.1 ADVANCES IN ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING TO DRIVE ADOPTION OF BIOMARKER TESTING TECHNOLOGIES 215
TABLE 110 MENTAL HEALTH SCREENING MARKET FOR BIOMARKER TESTING, BY COUNTRY, 2018–2021 (USD MILLION) 216
TABLE 111 MENTAL HEALTH SCREENING MARKET FOR BIOMARKER TESTING, BY COUNTRY, 2022–2029 (USD MILLION) 217
8 MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY 218
8.1 INTRODUCTION 219
TABLE 112 MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2018–2021 (USD MILLION) 219
TABLE 113 MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION) 219
8.2 SELF-SCREENING MHEALTH APPS 220
8.2.1 INCREASING AWARENESS AND TECHNOLOGICAL ADVANCEMENTS TO DRIVE ADOPTION OF MHEALTH APPS IN FUTURE 220
TABLE 114 MENTAL HEALTH SCREENING MARKET FOR SELF-SCREENING MHEALTH APPS, BY COUNTRY, 2018–2021 (USD MILLION) 221
TABLE 115 MENTAL HEALTH SCREENING MARKET FOR SELF-SCREENING MHEALTH APPS, BY COUNTRY, 2022–2029 (USD MILLION) 222
8.3 TELEHEALTH & VIRTUAL CARE SOLUTIONS 222
8.3.1 RISING DEMAND FOR ACCESSIBLE AND CONVENIENT HEALTHCARE SERVICES TO FUEL MARKET GROWTH 222
TABLE 116 MENTAL HEALTH SCREENING MARKET FOR TELEHEALTH & VIRTUAL CARE SOLUTIONS, BY COUNTRY, 2018–2021 (USD MILLION) 223
TABLE 117 MENTAL HEALTH SCREENING MARKET FOR TELEHEALTH & VIRTUAL CARE SOLUTIONS, BY COUNTRY, 2022–2029 (USD MILLION) 224
8.4 CONTINUOUS MONITORING WEARABLE DEVICES 224
8.4.1 SHIFT TOWARDS PROACTIVE AND PERSONALIZED HEALTHCARE TO DRIVE MARKET GROWTH 224
TABLE 118 MENTAL HEALTH SCREENING MARKET FOR CONTINUOUS MONITORING WEARABLE DEVICES, BY COUNTRY, 2018–2021 (USD MILLION) 225
TABLE 119 MENTAL HEALTH SCREENING MARKET FOR CONTINUOUS MONITORING WEARABLE DEVICES, BY COUNTRY, 2022–2029 (USD MILLION) 226
8.5 AI-BASED SCREENING TOOLS 226
8.5.1 HIGH COST ASSOCIATED WITH AI-BASED SCREENING TOOLS TO RESTRAIN MARKET GROWTH 226
TABLE 120 MENTAL HEALTH SCREENING MARKET FOR AI-BASED SCREENING TOOLS, BY COUNTRY, 2018–2021 (USD MILLION) 227
TABLE 121 MENTAL HEALTH SCREENING MARKET FOR AI-BASED SCREENING TOOLS, BY COUNTRY, 2022–2029 (USD MILLION) 228
8.6 REMOTE MENTAL HEALTH PLATFORMS 228
8.6.1 INCREASED ADOPTION OF REMOTE MENTAL HEALTH SCREENING PLATFORMS TO FAVOR MARKET GROWTH 228
TABLE 122 MENTAL HEALTH SCREENING MARKET FOR REMOTE MENTAL HEALTH PLATFORMS, BY COUNTRY, 2018–2021 (USD MILLION) 229
TABLE 123 MENTAL HEALTH SCREENING MARKET FOR REMOTE MENTAL HEALTH PLATFORMS, BY COUNTRY, 2022–2029 (USD MILLION) 230
9 MENTAL HEALTH SCREENING MARKET, BY AGE GROUP 231
9.1 INTRODUCTION 232
TABLE 124 MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2018–2021 (USD MILLION) 232
TABLE 125 MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2022–2029 (USD MILLION) 232
9.2 CHILDREN & ADOLESCENTS (AGE 0–18 YEARS) 233
9.2.1 GROWING PREVALENCE OF MENTAL HEALTH DISORDERS IN CHILDREN & ADOLESCENTS TO DRIVE MARKET GROWTH 233
TABLE 126 MENTAL HEALTH SCREENING MARKET FOR CHILDREN & ADOLESCENTS (0–18 YEARS), BY COUNTRY, 2018–2021 (USD MILLION) 234
TABLE 127 MENTAL HEALTH SCREENING MARKET FOR CHILDREN & ADOLESCENTS (0–18 YEARS), BY COUNTRY, 2022–2029 (USD MILLION) 235
9.3 ADULTS (AGE 19–64 YEARS) 235
9.3.1 GROWING POPULARITY OF WORKPLACE WELLNESS PROGRAMS TO BOOST DEMAND FOR MENTAL HEALTH SCREENING 235
TABLE 128 MENTAL HEALTH SCREENING MARKET FOR ADULTS (AGE 19–64 YEARS), BY COUNTRY, 2018–2021 (USD MILLION) 236
TABLE 129 MENTAL HEALTH SCREENING MARKET FOR ADULTS (AGE 19–64 YEARS), BY COUNTRY, 2022–2029 (USD MILLION) 237
9.4 SENIORS (AGE 65 AND ABOVE) 237
9.4.1 GROWING GERIATRIC POPULATION AND SUBSEQUENT INCREASE IN AGE-RELATED MENTAL DISORDERS TO BOOST MARKET 237
TABLE 130 MENTAL HEALTH SCREENING MARKET FOR SENIORS (AGE 65 AND ABOVE), BY COUNTRY, 2018–2021 (USD MILLION) 238
TABLE 131 MENTAL HEALTH SCREENING MARKET FOR SENIORS (AGE 65 AND ABOVE), BY COUNTRY, 2022–2029 (USD MILLION) 239

10 MENTAL HEALTH SCREENING MARKET, BY SETTING 240
10.1 INTRODUCTION 241
TABLE 132 MENTAL HEALTH SCREENING MARKET, BY SETTING, 2018–2021 (USD MILLION) 241
TABLE 133 MENTAL HEALTH SCREENING MARKET, BY SETTING, 2022–2029 (USD MILLION) 241
10.2 CLINICAL SETTINGS 242
10.2.1 SHIFT TOWARDS PREVENTIVE AND PATIENT-CENTRED CARE TO DRIVE MARKET GROWTH 242
TABLE 134 MENTAL HEALTH SCREENING MARKET FOR CLINICAL SETTINGS, BY COUNTRY, 2018–2021 (USD MILLION) 242
TABLE 135 MENTAL HEALTH SCREENING MARKET FOR CLINICAL SETTINGS, BY COUNTRY, 2022–2029 (USD MILLION) 243
10.3 EDUCATIONAL INSTITUTIONS 243
10.3.1 GROWING INITIATIVES TO BOOST GROWTH 243
TABLE 136 MENTAL HEALTH SCREENING MARKET FOR EDUCATIONAL INSTITUTIONS, BY COUNTRY, 2018–2021 (USD MILLION) 244
TABLE 137 MENTAL HEALTH SCREENING MARKET FOR EDUCATIONAL INSTITUTIONS, BY COUNTRY, 2022–2029 (USD MILLION) 245
10.4 WORKPLACE/CORPORATE PROGRAMS 245
10.4.1 RISING MENTAL HEALTH CHALLENGES AND DUTY OF CARE TO DRIVE MARKET GROWTH 245
TABLE 138 MENTAL HEALTH SCREENING MARKET FOR WORKPLACE/CORPORATE PROGRAMS, BY COUNTRY, 2018–2021 (USD MILLION) 246
TABLE 139 MENTAL HEALTH SCREENING MARKET FOR WORKPLACE/CORPORATE PROGRAMS, BY COUNTRY, 2022–2029 (USD MILLION) 247
10.5 ONLINE PLATFORMS 247
10.5.1 ACCESSIBLE AND PERSONALIZED ASSESSMENTS TO DRIVE DEMAND 247
TABLE 140 MENTAL HEALTH SCREENING MARKET FOR ONLINE PLATFORMS, BY COUNTRY, 2018–2021 (USD MILLION) 248
TABLE 141 MENTAL HEALTH SCREENING MARKET FOR ONLINE PLATFORMS, BY COUNTRY, 2022–2029 (USD MILLION) 249
10.6 OTHER SETTINGS 249
TABLE 142 MENTAL HEALTH SCREENING MARKET FOR OTHER SETTINGS, BY COUNTRY, 2018–2021 (USD MILLION) 250
TABLE 143 MENTAL HEALTH SCREENING MARKET FOR OTHER SETTINGS, BY COUNTRY, 2022–2029 (USD MILLION) 251

11 MENTAL HEALTH SCREENING MARKET, BY REGION 252
11.1 INTRODUCTION 253
TABLE 144 MENTAL HEALTH SCREENING MARKET, BY REGION, 2018–2021 (USD MILLION) 253
TABLE 145 MENTAL HEALTH SCREENING MARKET, BY REGION, 2022–2029 (USD MILLION) 253

11.2 NORTH AMERICA 254
FIGURE 32 NORTH AMERICA: MARKET SNAPSHOT 255
TABLE 146 NORTH AMERICA: MENTAL HEALTH SCREENING MARKET, BY COUNTRY, 2018–2021 (USD MILLION) 255
TABLE 147 NORTH AMERICA: MENTAL HEALTH SCREENING MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 256
TABLE 148 NORTH AMERICA: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2018–2021 (USD MILLION) 256
TABLE 149 NORTH AMERICA: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 256
TABLE 150 NORTH AMERICA: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 257
TABLE 151 NORTH AMERICA: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 257
TABLE 152 NORTH AMERICA: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 258
TABLE 153 NORTH AMERICA: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 258
TABLE 154 NORTH AMERICA: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 259
TABLE 155 NORTH AMERICA: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 259
TABLE 156 NORTH AMERICA: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 260
TABLE 157 NORTH AMERICA: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 260
TABLE 158 NORTH AMERICA: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2018–2021 (USD MILLION) 260
TABLE 159 NORTH AMERICA: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2022–2029 (USD MILLION) 261
TABLE 160 NORTH AMERICA: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2018–2021 (USD MILLION) 261
TABLE 161 NORTH AMERICA: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2022–2029 (USD MILLION) 262
TABLE 162 NORTH AMERICA: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2018–2021 (USD MILLION) 262
TABLE 163 NORTH AMERICA: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2022–2029 (USD MILLION) 263
TABLE 164 NORTH AMERICA: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2018–2021 (USD MILLION) 263
TABLE 165 NORTH AMERICA: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION) 264
TABLE 166 NORTH AMERICA: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2018–2021 (USD MILLION) 264
TABLE 167 NORTH AMERICA: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2022–2029 (USD MILLION) 265
TABLE 168 NORTH AMERICA: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2018–2021 (USD MILLION) 265
TABLE 169 NORTH AMERICA: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2022–2029 (USD MILLION) 266
11.2.1 NORTH AMERICA: RECESSION IMPACT 266
11.2.2 US 266
11.2.2.1 US to dominate North American mental health screening market 266
TABLE 170 US: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2018–2021 (USD MILLION) 267
TABLE 171 US: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 267
TABLE 172 US: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 268
TABLE 173 US: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 268
TABLE 174 US: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 269
TABLE 175 US: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 269
TABLE 176 US: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 270
TABLE 177 US: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 270
TABLE 178 US: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 271
TABLE 179 US: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 271
TABLE 180 US: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2018–2021 (USD MILLION) 271
TABLE 181 US: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2022–2029 (USD MILLION) 272
TABLE 182 US: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2018–2021 (USD MILLION) 272
TABLE 183 US: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2022–2029 (USD MILLION) 273
TABLE 184 US: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2018–2021 (USD MILLION) 273
TABLE 185 US: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2022–2029 (USD MILLION) 274
TABLE 186 US: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2018–2021 (USD MILLION) 274
TABLE 187 US: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION) 275
TABLE 188 US: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2018–2021 (USD MILLION) 275
TABLE 189 US: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2022–2029 (USD MILLION) 275
TABLE 190 US: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2018–2021 (USD MILLION) 276
TABLE 191 US: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2022–2029 (USD MILLION) 276
11.2.3 CANADA 276
11.2.3.1 Growing investments in mental health and well-being to contribute to market growth 276
TABLE 192 CANADA: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2018–2021 (USD MILLION) 277
TABLE 193 CANADA: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 277
TABLE 194 CANADA: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 278
TABLE 195 CANADA: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 278
TABLE 196 CANADA: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 279
TABLE 197 CANADA: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 279
TABLE 198 CANADA: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 280
TABLE 199 CANADA: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 280
TABLE 200 CANADA: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 281
TABLE 201 CANADA: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 281
TABLE 202 CANADA: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2018–2021 (USD MILLION) 281
TABLE 203 CANADA: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2022–2029 (USD MILLION) 282
TABLE 204 CANADA: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2018–2021 (USD MILLION) 282
TABLE 205 CANADA: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2022–2029 (USD MILLION) 283
TABLE 206 CANADA: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2018–2021 (USD MILLION) 283
TABLE 207 CANADA: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2022–2029 (USD MILLION) 284
TABLE 208 CANADA: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2018–2021 (USD MILLION) 284
TABLE 209 CANADA: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION) 285
TABLE 210 CANADA: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2018–2021 (USD MILLION) 285
TABLE 211 CANADA: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2022–2029 (USD MILLION) 286
TABLE 212 CANADA: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2018–2021 (USD MILLION) 286
TABLE 213 CANADA: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2022–2029 (USD MILLION) 286

11.3 EUROPE 287
TABLE 214 EUROPE: MENTAL HEALTH SCREENING MARKET, BY COUNTRY, 2018–2021 (USD MILLION) 287
TABLE 215 EUROPE: MENTAL HEALTH SCREENING MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 288
TABLE 216 EUROPE: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2018–2021 (USD MILLION) 288
TABLE 217 EUROPE: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 288
TABLE 218 EUROPE: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 289
TABLE 219 EUROPE: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 289
TABLE 220 EUROPE: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 290
TABLE 221 EUROPE: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 290
TABLE 222 EUROPE: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 291
TABLE 223 EUROPE: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 291
TABLE 224 EUROPE: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 292
TABLE 225 EUROPE: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 292
TABLE 226 EUROPE: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2018–2021 (USD MILLION) 292
TABLE 227 EUROPE: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2022–2029 (USD MILLION) 293
TABLE 228 EUROPE: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2018–2021 (USD MILLION) 293
TABLE 229 EUROPE: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2022–2029 (USD MILLION) 294
TABLE 230 EUROPE: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2018–2021 (USD MILLION) 294
TABLE 231 EUROPE: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2022–2029 (USD MILLION) 295
TABLE 232 EUROPE: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2018–2021 (USD MILLION) 295
TABLE 233 EUROPE: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION) 296
TABLE 234 EUROPE: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2018–2021 (USD MILLION) 296
TABLE 235 EUROPE: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2022–2029 (USD MILLION) 297
TABLE 236 EUROPE: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2018–2021 (USD MILLION) 297
TABLE 237 EUROPE: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2022–2029 (USD MILLION) 297
11.3.1 EUROPE: RECESSION IMPACT 298
11.3.2 UK 298
11.3.2.1 Long waiting periods and inadequate access to care to favor market growth 298
TABLE 238 UK: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2018–2021 (USD MILLION) 299
TABLE 239 UK: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 299
TABLE 240 UK: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 300
TABLE 241 UK: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 300
TABLE 242 UK: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 301
TABLE 243 UK: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 301
TABLE 244 UK: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 302
TABLE 245 UK: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 302
TABLE 246 UK: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 303
TABLE 247 UK: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 303
TABLE 248 UK: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2018–2021 (USD MILLION) 303
TABLE 249 UK: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2022–2029 (USD MILLION) 304
TABLE 250 UK: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2018–2021 (USD MILLION) 304
TABLE 251 UK: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2022–2029 (USD MILLION) 305
TABLE 252 UK: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2018–2021 (USD MILLION) 305
TABLE 253 UK: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2022–2029 (USD MILLION) 306
TABLE 254 UK: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2018–2021 (USD MILLION) 306
TABLE 255 UK: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION) 307
TABLE 256 UK: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2018–2021 (USD MILLION) 307
TABLE 257 UK: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2022–2029 (USD MILLION) 307
TABLE 258 UK: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2018–2021 (USD MILLION) 308
TABLE 259 UK: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2022–2029 (USD MILLION) 308
11.3.3 GERMANY 308
11.3.3.1 Large patient base and growing burden on health providers to drive demand for HCIT solutions 308
TABLE 260 GERMANY: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2018–2021 (USD MILLION) 309
TABLE 261 GERMANY: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 309
TABLE 262 GERMANY: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 310
TABLE 263 GERMANY: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 310
TABLE 264 GERMANY: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 311
TABLE 265 GERMANY: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 311
TABLE 266 GERMANY: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 312
TABLE 267 GERMANY: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 312
TABLE 268 GERMANY: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 313
TABLE 269 GERMANY: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 313
TABLE 270 GERMANY: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2018–2021 (USD MILLION) 313
TABLE 271 GERMANY: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2022–2029 (USD MILLION) 314
TABLE 272 GERMANY: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2018–2021 (USD MILLION) 314
TABLE 273 GERMANY: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2022–2029 (USD MILLION) 315
TABLE 274 GERMANY: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2018–2021 (USD MILLION) 315
TABLE 275 GERMANY: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2022–2029 (USD MILLION) 316
TABLE 276 GERMANY: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2018–2021 (USD MILLION) 316
TABLE 277 GERMANY: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION) 317
TABLE 278 GERMANY: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2018–2021 (USD MILLION) 317
TABLE 279 GERMANY: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2022–2029 (USD MILLION) 318
TABLE 280 GERMANY: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2018–2021 (USD MILLION) 318
TABLE 281 GERMANY: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2022–2029 (USD MILLION) 319
11.3.4 FRANCE 319
11.3.4.1 High prevalence of behavioral disorders to drive support for implementing mental health screening solutions in France 319
TABLE 282 FRANCE: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2018–2021 (USD MILLION) 319
TABLE 283 FRANCE: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 320
TABLE 284 FRANCE: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 320
TABLE 285 FRANCE: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 321
TABLE 286 FRANCE: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 321
TABLE 287 FRANCE: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 322
TABLE 288 FRANCE: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 322
TABLE 289 FRANCE: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 323
TABLE 290 FRANCE: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 323
TABLE 291 FRANCE: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 324
TABLE 292 FRANCE: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2018–2021 (USD MILLION) 324
TABLE 293 FRANCE: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2022–2029 (USD MILLION) 325
TABLE 294 FRANCE: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2018–2021 (USD MILLION) 325
TABLE 295 FRANCE: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2022–2029 (USD MILLION) 326
TABLE 296 FRANCE: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2018–2021 (USD MILLION) 326
TABLE 297 FRANCE: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2022–2029 (USD MILLION) 327
TABLE 298 FRANCE: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2018–2021 (USD MILLION) 327
TABLE 299 FRANCE: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION) 328
TABLE 300 FRANCE: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2018–2021 (USD MILLION) 328
TABLE 301 FRANCE: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2022–2029 (USD MILLION) 329
TABLE 302 FRANCE: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2018–2021 (USD MILLION) 329
TABLE 303 FRANCE: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2022–2029 (USD MILLION) 329
11.3.5 REST OF EUROPE 330
TABLE 304 REST OF EUROPE: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2018–2021 (USD MILLION) 330
TABLE 305 REST OF EUROPE: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 331
TABLE 306 REST OF EUROPE: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 331
TABLE 307 REST OF EUROPE: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 332
TABLE 308 REST OF EUROPE: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 332
TABLE 309 REST OF EUROPE: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 333
TABLE 310 REST OF EUROPE: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 333
TABLE 311 REST OF EUROPE: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 334
TABLE 312 REST OF EUROPE: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 334
TABLE 313 REST OF EUROPE: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 335
TABLE 314 REST OF EUROPE: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2018–2021 (USD MILLION) 335
TABLE 315 REST OF EUROPE: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2022–2029 (USD MILLION) 336
TABLE 316 REST OF EUROPE: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2018–2021 (USD MILLION) 336
TABLE 317 REST OF EUROPE: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2022–2029 (USD MILLION) 337
TABLE 318 REST OF EUROPE: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2018–2021 (USD MILLION) 337
TABLE 319 REST OF EUROPE: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2022–2029 (USD MILLION) 338
TABLE 320 REST OF EUROPE: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2018–2021 (USD MILLION) 338
TABLE 321 REST OF EUROPE: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION) 339
TABLE 322 REST OF EUROPE: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2018–2021 (USD MILLION) 339
TABLE 323 REST OF EUROPE: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2022–2029 (USD MILLION) 340
TABLE 324 REST OF EUROPE: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2018–2021 (USD MILLION) 340
TABLE 325 REST OF EUROPE: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2022–2029 (USD MILLION) 341
11.4 ASIA PACIFIC 341
FIGURE 33 ASIA PACIFIC: MARKET SNAPSHOT 342
TABLE 326 ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET, BY COUNTRY, 2018–2021 (USD MILLION) 343
TABLE 327 ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 343
TABLE 328 ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2018–2021 (USD MILLION) 343
TABLE 329 ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 344
TABLE 330 ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 344
TABLE 331 ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 345
TABLE 332 ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 345
TABLE 333 ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 346
TABLE 334 ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 346
TABLE 335 ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 347
TABLE 336 ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 347
TABLE 337 ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 348
TABLE 338 ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2018–2021 (USD MILLION) 348
TABLE 339 ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2022–2029 (USD MILLION) 349
TABLE 340 ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2018–2021 (USD MILLION) 349
TABLE 341 ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2022–2029 (USD MILLION) 350
TABLE 342 ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2018–2021 (USD MILLION) 350
TABLE 343 ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2022–2029 (USD MILLION) 351
TABLE 344 ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2018–2021 (USD MILLION) 351
TABLE 345 ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION) 352
TABLE 346 ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2018–2021 (USD MILLION) 352
TABLE 347 ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2022–2029 (USD MILLION) 353
TABLE 348 ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2018–2021 (USD MILLION) 353
TABLE 349 ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2022–2029 (USD MILLION) 354
11.4.1 ASIA PACIFIC: RECESSION IMPACT 354
11.4.2 CHINA 354
11.4.2.1 Rising incidence of mental illnesses to drive demand for care solutions in China 354
TABLE 350 CHINA: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2018–2021 (USD MILLION) 355
TABLE 351 CHINA: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 355
TABLE 352 CHINA: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 356
TABLE 353 CHINA: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 356
TABLE 354 CHINA: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 357
TABLE 355 CHINA: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 357
TABLE 356 CHINA: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 358
TABLE 357 CHINA: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 358
TABLE 358 CHINA: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 359
TABLE 359 CHINA: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 359
TABLE 360 CHINA: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2018–2021 (USD MILLION) 359
TABLE 361 CHINA: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2022–2029 (USD MILLION) 360
TABLE 362 CHINA: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2018–2021 (USD MILLION) 360
TABLE 363 CHINA: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2022–2029 (USD MILLION) 361
TABLE 364 CHINA: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2018–2021 (USD MILLION) 361
TABLE 365 CHINA: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2022–2029 (USD MILLION) 362
TABLE 366 CHINA: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2018–2021 (USD MILLION) 362
TABLE 367 CHINA: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION) 363
TABLE 368 CHINA: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2018–2021 (USD MILLION) 363
TABLE 369 CHINA: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2022–2029 (USD MILLION) 364
TABLE 370 CHINA: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2018–2021 (USD MILLION) 364
TABLE 371 CHINA: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2022–2029 (USD MILLION) 364
11.4.3 JAPAN 365
11.4.3.1 Rising geriatric population in Japan and subsequent increase in age-related mental disorders to boost market 365
TABLE 372 JAPAN: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2018–2021 (USD MILLION) 365
TABLE 373 JAPAN: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 366
TABLE 374 JAPAN: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 366
TABLE 375 JAPAN: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 367
TABLE 376 JAPAN: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 367
TABLE 377 JAPAN: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 368
TABLE 378 JAPAN: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 368
TABLE 379 JAPAN: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 369
TABLE 380 JAPAN: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 369
TABLE 381 JAPAN: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 370
TABLE 382 JAPAN: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2018–2021 (USD MILLION) 370
TABLE 383 JAPAN: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2022–2029 (USD MILLION) 371
TABLE 384 JAPAN: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2018–2021 (USD MILLION) 371
TABLE 385 JAPAN: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2022–2029 (USD MILLION) 372
TABLE 386 JAPAN: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2018–2021 (USD MILLION) 372
TABLE 387 JAPAN: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2022–2029 (USD MILLION) 373
TABLE 388 JAPAN: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2018–2021 (USD MILLION) 373
TABLE 389 JAPAN: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION) 374
TABLE 390 JAPAN: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2018–2021 (USD MILLION) 374
TABLE 391 JAPAN: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2022–2029 (USD MILLION) 375
TABLE 392 JAPAN: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2018–2021 (USD MILLION) 375
TABLE 393 JAPAN: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2022–2029 (USD MILLION) 375
11.4.4 INDIA 376
11.4.4.1 Inadequate workforce and lack of access to drive adoption of solutions 376
TABLE 394 INDIA: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2018–2021 (USD MILLION) 376
TABLE 395 INDIA: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 377
TABLE 396 INDIA: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 377
TABLE 397 INDIA: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 378
TABLE 398 INDIA: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 378
TABLE 399 INDIA: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 379
TABLE 400 INDIA: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 379
TABLE 401 INDIA: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 380
TABLE 402 INDIA: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 380
TABLE 403 INDIA: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 381
TABLE 404 INDIA: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2018–2021 (USD MILLION) 381
TABLE 405 INDIA: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2022–2029 (USD MILLION) 382
TABLE 406 INDIA: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2018–2021 (USD MILLION) 382
TABLE 407 INDIA: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2022–2029 (USD MILLION) 383
TABLE 408 INDIA: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2018–2021 (USD MILLION) 383
TABLE 409 INDIA: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2022–2029 (USD MILLION) 384
TABLE 410 INDIA: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2018–2021 (USD MILLION) 384
TABLE 411 INDIA: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION) 385
TABLE 412 INDIA: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2018–2021 (USD MILLION) 385
TABLE 413 INDIA: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2022–2029 (USD MILLION) 386
TABLE 414 INDIA: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2018–2021 (USD MILLION) 386
TABLE 415 INDIA: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2022–2029 (USD MILLION) 386

11.4.5 REST OF ASIA PACIFIC 387
TABLE 416 REST OF ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2018–2021 (USD MILLION) 387
TABLE 417 REST OF ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 388
TABLE 418 REST OF ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 388
TABLE 419 REST OF ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 389
TABLE 420 REST OF ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 389
TABLE 421 REST OF ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 390
TABLE 422 REST OF ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 390
TABLE 423 REST OF ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 391
TABLE 424 REST OF ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 391
TABLE 425 REST OF ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 392
TABLE 426 REST OF ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2018–2021 (USD MILLION) 392
TABLE 427 REST OF ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2022–2029 (USD MILLION) 393
TABLE 428 REST OF ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2018–2021 (USD MILLION) 393
TABLE 429 REST OF ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2022–2029 (USD MILLION) 394
TABLE 430 REST OF ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2018–2021 (USD MILLION) 394
TABLE 431 REST OF ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2022–2029 (USD MILLION) 395
TABLE 432 REST OF ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2018–2021 (USD MILLION) 395
TABLE 433 REST OF ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION) 396
TABLE 434 REST OF ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2018–2021 (USD MILLION) 396
TABLE 435 REST OF ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2022–2029 (USD MILLION) 397
TABLE 436 REST OF ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2018–2021 (USD MILLION) 397
TABLE 437 REST OF ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2022–2029 (USD MILLION) 398
11.5 LATIN AMERICA 398
TABLE 438 LATIN AMERICA: MENTAL HEALTH SCREENING MARKET, BY COUNTRY, 2018–2021 (USD MILLION) 399
TABLE 439 LATIN AMERICA: MENTAL HEALTH SCREENING MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 399
TABLE 440 LATIN AMERICA: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2018–2021 (USD MILLION) 399
TABLE 441 LATIN AMERICA: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 400
TABLE 442 LATIN AMERICA: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 400
TABLE 443 LATIN AMERICA: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 401
TABLE 444 LATIN AMERICA: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 401
TABLE 445 LATIN AMERICA: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 402
TABLE 446 LATIN AMERICA: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 402
TABLE 447 LATIN AMERICA: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 403
TABLE 448 LATIN AMERICA: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 403
TABLE 449 LATIN AMERICA: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 404
TABLE 450 LATIN AMERICA: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2018–2021 (USD MILLION) 404
TABLE 451 LATIN AMERICA: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2022–2029 (USD MILLION) 405
TABLE 452 LATIN AMERICA: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2018–2021 (USD MILLION) 405
TABLE 453 LATIN AMERICA: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2022–2029 (USD MILLION) 406
TABLE 454 LATIN AMERICA: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2018–2021 (USD MILLION) 406
TABLE 455 LATIN AMERICA: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2022–2029 (USD MILLION) 407
TABLE 456 LATIN AMERICA: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2018–2021 (USD MILLION) 407
TABLE 457 LATIN AMERICA: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION) 408
TABLE 458 LATIN AMERICA: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2018–2021 (USD MILLION) 408
TABLE 459 LATIN AMERICA: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2022–2029 (USD MILLION) 409
TABLE 460 LATIN AMERICA: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2018–2021 (USD MILLION) 409
TABLE 461 LATIN AMERICA: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2022–2029 (USD MILLION) 410
11.5.1 LATIN AMERICA: RECESSION IMPACT 410
11.5.2 BRAZIL 410
11.5.2.1 Large healthcare industry and increased investments in healthcare to boost market 410
TABLE 462 BRAZIL: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2018–2021 (USD MILLION) 411
TABLE 463 BRAZIL: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 411
TABLE 464 BRAZIL: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 412
TABLE 465 BRAZIL: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 412
TABLE 466 BRAZIL: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 413
TABLE 467 BRAZIL: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 413
TABLE 468 BRAZIL: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 414
TABLE 469 BRAZIL: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 414
TABLE 470 BRAZIL: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 415
TABLE 471 BRAZIL: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 415
TABLE 472 BRAZIL: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2018–2021 (USD MILLION) 415
TABLE 473 BRAZIL: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2022–2029 (USD MILLION) 416
TABLE 474 BRAZIL: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2018–2021 (USD MILLION) 416
TABLE 475 BRAZIL: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2022–2029 (USD MILLION) 417
TABLE 476 BRAZIL: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2018–2021 (USD MILLION) 417
TABLE 477 BRAZIL: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2022–2029 (USD MILLION) 418
TABLE 478 BRAZIL: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2018–2021 (USD MILLION) 418
TABLE 479 BRAZIL: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION) 419
TABLE 480 BRAZIL: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2018–2021 (USD MILLION) 419
TABLE 481 BRAZIL: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2022–2029 (USD MILLION) 420
TABLE 482 BRAZIL: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2018–2021 (USD MILLION) 420
TABLE 483 BRAZIL: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2022–2029 (USD MILLION) 420
11.5.3 MEXICO 421
11.5.3.1 Growing number of mental health patients to drive market 421
TABLE 484 MEXICO: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2018–2021 (USD MILLION) 421
TABLE 485 MEXICO: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 422
TABLE 486 MEXICO: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 422
TABLE 487 MEXICO: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 423
TABLE 488 MEXICO: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 423
TABLE 489 MEXICO: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 424
TABLE 490 MEXICO: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 424
TABLE 491 MEXICO: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 425
TABLE 492 MEXICO: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 425
TABLE 493 MEXICO: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 425
TABLE 494 MEXICO: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2018–2021 (USD MILLION) 426
TABLE 495 MEXICO: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2022–2029 (USD MILLION) 426
TABLE 496 MEXICO: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2018–2021 (USD MILLION) 427
TABLE 497 MEXICO: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2022–2029 (USD MILLION) 427
TABLE 498 MEXICO: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2018–2021 (USD MILLION) 428
TABLE 499 MEXICO: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2022–2029 (USD MILLION) 428
TABLE 500 MEXICO: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2018–2021 (USD MILLION) 429
TABLE 501 MEXICO: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION) 429
TABLE 502 MEXICO: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2018–2021 (USD MILLION) 429
TABLE 503 MEXICO: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2022–2029 (USD MILLION) 430
TABLE 504 MEXICO: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2018–2021 (USD MILLION) 430
TABLE 505 MEXICO: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2022–2029 (USD MILLION) 430
11.5.4 REST OF LATIN AMERICA 431
TABLE 506 REST OF LATIN AMERICA: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2018–2021 (USD MILLION) 431
TABLE 507 REST OF LATIN AMERICA: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 431
TABLE 508 REST OF LATIN AMERICA: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 432
TABLE 509 REST OF LATIN AMERICA: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 432
TABLE 510 REST OF LATIN AMERICA: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 433
TABLE 511 REST OF LATIN AMERICA: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 433
TABLE 512 REST OF LATIN AMERICA: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 434
TABLE 513 REST OF LATIN AMERICA: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 434
TABLE 514 REST OF LATIN AMERICA: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 435
TABLE 515 REST OF LATIN AMERICA: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 435
TABLE 516 REST OF LATIN AMERICA: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2018–2021 (USD MILLION) 435
TABLE 517 REST OF LATIN AMERICA: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2022–2029 (USD MILLION) 436
TABLE 518 REST OF LATIN AMERICA: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2018–2021 (USD MILLION) 436
TABLE 519 REST OF LATIN AMERICA: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2022–2029 (USD MILLION) 437
TABLE 520 REST OF LATIN AMERICA: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2018–2021 (USD MILLION) 437
TABLE 521 REST OF LATIN AMERICA: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2022–2029 (USD MILLION) 438
TABLE 522 REST OF LATIN AMERICA: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2018–2021 (USD MILLION) 438
TABLE 523 REST OF LATIN AMERICA: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION) 439
TABLE 524 REST OF LATIN AMERICA: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2018–2021 (USD MILLION) 439
TABLE 525 REST OF LATIN AMERICA: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2022–2029 (USD MILLION) 440
TABLE 526 REST OF LATIN AMERICA: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2018–2021 (USD MILLION) 440
TABLE 527 REST OF LATIN AMERICA: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2022–2029 (USD MILLION) 441
11.6 MIDDLE EAST & AFRICA 441
TABLE 528 MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET, BY COUNTRY, 2018–2021 (USD MILLION) 442
TABLE 529 MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 442
TABLE 530 MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2018–2021 (USD MILLION) 442
TABLE 531 MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 443
TABLE 532 MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 443
TABLE 533 MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 444
TABLE 534 MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 444
TABLE 535 MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 445
TABLE 536 MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 445
TABLE 537 MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 446
TABLE 538 MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 446
TABLE 539 MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 447
TABLE 540 MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2018–2021 (USD MILLION) 447
TABLE 541 MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2022–2029 (USD MILLION) 448
TABLE 542 MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2018–2021 (USD MILLION) 448
TABLE 543 MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2022–2029 (USD MILLION) 449
TABLE 544 MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2018–2021 (USD MILLION) 449
TABLE 545 MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2022–2029 (USD MILLION) 450
TABLE 546 MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2018–2021 (USD MILLION) 450
TABLE 547 MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION) 451
TABLE 548 MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2018–2021 (USD MILLION) 451
TABLE 549 MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2022–2029 (USD MILLION) 452
TABLE 550 MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2018–2021 (USD MILLION) 452
TABLE 551 MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2022–2029 (USD MILLION) 452
11.6.1 MIDDLE EAST & AFRICA: RECESSION IMPACT 453
11.6.2 GCC COUNTRIES 453
11.6.2.1 Growing initiatives to address mental health issues to drive growth 453
TABLE 552 GCC COUNTRIES: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2018–2021 (USD MILLION) 453
TABLE 553 GCC COUNTRIES: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 454
TABLE 554 GCC COUNTRIES: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 454
TABLE 555 GCC COUNTRIES: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 455
TABLE 556 GCC COUNTRIES: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 455
TABLE 557 GCC COUNTRIES: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 456
TABLE 558 GCC COUNTRIES: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 456
TABLE 559 GCC COUNTRIES: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 457
TABLE 560 GCC COUNTRIES: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 457
TABLE 561 GCC COUNTRIES: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 458
TABLE 562 GCC COUNTRIES: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2018–2021 (USD MILLION) 458
TABLE 563 GCC COUNTRIES: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2022–2029 (USD MILLION) 458
TABLE 564 GCC COUNTRIES: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2018–2021 (USD MILLION) 459
TABLE 565 GCC COUNTRIES: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2022–2029 (USD MILLION) 459
TABLE 566 GCC COUNTRIES: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2018–2021 (USD MILLION) 460
TABLE 567 GCC COUNTRIES: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2022–2029 (USD MILLION) 460
TABLE 568 GCC COUNTRIES: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2018–2021 (USD MILLION) 461
TABLE 569 GCC COUNTRIES: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION) 461
TABLE 570 GCC COUNTRIES: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2018–2021 (USD MILLION) 462
TABLE 571 GCC COUNTRIES: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2022–2029 (USD MILLION) 462
TABLE 572 GCC COUNTRIES: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2018–2021 (USD MILLION) 462
TABLE 573 GCC COUNTRIES: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2022–2029 (USD MILLION) 463
11.6.3 REST OF MIDDLE EAST & AFRICA 463
TABLE 574 REST OF MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2018–2021 (USD MILLION) 463
TABLE 575 REST OF MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 464
TABLE 576 REST OF MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 464
TABLE 577 REST OF MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 465
TABLE 578 REST OF MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 465
TABLE 579 REST OF MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 466
TABLE 580 REST OF MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 466
TABLE 581 REST OF MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 467
TABLE 582 REST OF MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 467
TABLE 583 REST OF MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 468
TABLE 584 REST OF MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2018–2021 (USD MILLION) 468
TABLE 585 REST OF MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2022–2029 (USD MILLION) 468
TABLE 586 REST OF MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2018–2021 (USD MILLION) 469
TABLE 587 REST OF MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2022–2029 (USD MILLION) 469
TABLE 588 REST OF MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2018–2021 (USD MILLION) 470
TABLE 589 REST OF MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2022–2029 (USD MILLION) 470
TABLE 590 REST OF MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2018–2021 (USD MILLION) 471
TABLE 591 REST OF MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION) 471
TABLE 592 REST OF MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2018–2021 (USD MILLION) 472
TABLE 593 REST OF MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2022–2029 (USD MILLION) 472
TABLE 594 REST OF MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2018–2021 (USD MILLION) 472
TABLE 595 REST OF MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2022–2029 (USD MILLION) 473
12 COMPETITIVE LANDSCAPE 474
12.1 OVERVIEW 474
12.2 STRATEGIES ADOPTED BY KEY PLAYERS 474
FIGURE 34 MENTAL HEALTH SCREENING MARKET: STRATEGIES ADOPTED BY KEY PLAYERS 475
12.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS (2022) 476
FIGURE 35 MENTAL HEALTH SCREENING MARKET: REVENUE ANALYSIS FOR KEY PLAYERS, 2018–2022 476
12.4 MARKET SHARE ANALYSIS (2022) 476
12.4.1 MARKET SHARE ANALYSIS OF KEY PLAYERS IN MENTAL HEALTH SCREENING WEARABLE DEVICES MARKET (2022) 476
FIGURE 36 MENTAL HEALTH SCREENING WEARABLE DEVICES MARKET: MARKET SHARE ANALYSIS FOR KEY PLAYERS, 2022 477
TABLE 596 MENTAL HEALTH SCREENING WEARABLE DEVICES MARKET: DEGREE OF COMPETITION 477
12.4.2 MARKET RANKING ANALYSIS OF KEY PLAYERS IN MENTAL HEALTH SCREENING MARKET (2022) 478
12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 479
12.5.1 STARS 479
12.5.2 PERVASIVE PLAYERS 479
12.5.3 EMERGING LEADERS 479
12.5.4 PARTICIPANTS 479
FIGURE 37 MENTAL HEALTH SCREENING MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023 480
12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 481
FIGURE 38 MENTAL HEALTH SCREENING MARKET: COMPANY FOOTPRINT 481
TABLE 597 MENTAL HEALTH SCREENING MARKET: REGION FOOTPRINT 482
TABLE 598 MENTAL HEALTH SCREENING MARKET: APPLICATION FOOTPRINT 483
TABLE 599 MENTAL HEALTH SCREENING MARKET: SCREENING METHOD FOOTPRINT 484
TABLE 600 MENTAL HEALTH SCREENING MARKET: TECHNOLOGY FOOTPRINT 485
TABLE 601 MENTAL HEALTH SCREENING MARKET: AGE GROUP FOOTPRINT 486
12.6 COMPANY EVALUATION MATRIX: SMES/STARTUPS, 2023 487
12.6.1 PROGRESSIVE COMPANIES 487
12.6.2 DYNAMIC COMPANIES 487
12.6.3 RESPONSIVE COMPANIES 487
12.6.4 STARTING BLOCKS 487
FIGURE 39 MENTAL HEALTH SCREENING MARKET: COMPANY EVALUATION MATRIX (SMES/START-UPS), 2023 488
12.6.5 COMPETITIVE BENCHMARKING: SMES/STARTUPS, 2023 489
TABLE 602 MENTAL HEALTH SCREENING MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS 489
TABLE 603 MENTAL HEALTH SCREENING MARKET: COMPETITIVE BENCHMARKING OF STARTUP/ SME PLAYERS 490
12.7 VALUATION AND FINANCIAL METRICS OF MENTAL HEALTH SCREENING WEARABLE DEVICE VENDORS 491
FIGURE 40 MENTAL HEALTH SCREENING MARKET: EV/EBITDA OF KEY VENDORS 491
FIGURE 41 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF MENTAL HEALTH SCREENING WEARABLE DEVICE VENDORS 491
12.8 PRODUCT COMPARATIVE ANALYSIS 492
FIGURE 42 MENTAL HEALTH SCREENING MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS, BY SCREENING METHOD 492
12.8.1 TOTAL BRAIN PLATFORM 493
12.8.2 AIBERRY MENTAL HEALTH ASSESSMENT & SCREENING 493
12.8.3 HEADSPACE FOR WORK 493
12.8.4 QUARTET 493
12.9 COMPETITIVE SCENARIO 494
12.9.1 MENTAL HEALTH SCREENING MARKET: PRODUCT LAUNCHES 494
TABLE 604 MENTAL HEALTH SCREENING MARKET: PRODUCT LAUNCHES 494
12.9.2 MENTAL HEALTH SCREENING MARKET: DEALS 495
TABLE 605 MENTAL HEALTH SCREENING MARKET: DEALS 495
12.9.3 MENTAL HEALTH SCREENING MARKET: OTHER DEVELOPMENTS 496
TABLE 606 MENTAL HEALTH SCREENING MARKET: OTHER DEVELOPMENTS 496
13 COMPANY PROFILES 497
13.1 KEY PLAYERS 497
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
13.1.1 SONDERMIND (TOTAL BRAIN) 497
TABLE 607 SONDERMIND: COMPANY OVERVIEW 497
TABLE 608 SONDERMIND: DEALS 498
TABLE 609 SONDERMIND: EXPANSIONS 499
13.1.2 RIVERSIDE COMMUNITY CARE (MINDWISE INNOVATIONS) 500
TABLE 610 RIVERSIDE COMMUNITY CARE: COMPANY OVERVIEW 500
13.1.3 PROEM BEHAVIORAL HEALTH 502
TABLE 611 PROEM BEHAVIORAL HEALTH: COMPANY OVERVIEW 502
TABLE 612 PROEM BEHAVIORAL HEALTH: DEALS 503
TABLE 613 PROEM BEHAVIORAL HEALTH: OTHER DEVELOPMENTS 504
13.1.4 HEADSPACE HEALTH 505
TABLE 614 HEADSPACE HEALTH: COMPANY OVERVIEW 505
13.1.5 QUARTET HEALTH, INC. 507
TABLE 615 QUARTET HEALTH, INC.: COMPANY OVERVIEW 507
TABLE 616 QUARTET HEALTH, INC.: DEALS 508
13.1.6 CLARIGENT HEALTH 510
TABLE 617 CLARIGENT HEALTH: COMPANY OVERVIEW 510
TABLE 618 CLARIGENT HEALTH: PRODUCT LAUNCHES 511
TABLE 619 CLARIGENT HEALTH: DEALS 511
13.1.7 ELLIPSIS HEALTH, INC. 512
TABLE 620 ELLIPSIS HEALTH: COMPANY OVERVIEW 512
TABLE 621 ELLIPSIS HEALTH, INC.: DEALS 513
13.1.8 ADAPTIVE TESTING TECHNOLOGIES 514
TABLE 622 ADAPTIVE TESTING TECHNOLOGIES: COMPANY OVERVIEW 514
13.1.9 AIBERRY 515
TABLE 623 AIBERRY: COMPANY OVERVIEW 515
TABLE 624 AIBERRY: PRODUCT ENHANCEMENTS 516
13.1.10 KINTSUGI MINDFUL WELLNESS, INC. 517
TABLE 625 KINTSUGI MINDFUL WELLNESS, INC.: COMPANY OVERVIEW 517
13.1.11 THYMIA LIMITED 518
TABLE 626 THYMIA LIMITED: COMPANY OVERVIEW 518
13.1.12 CANARY SPEECH, INC. 519
TABLE 627 CANARY SPEECH, INC.: COMPANY OVERVIEW 519
TABLE 628 CANARY SPEECH, INC.: DEALS 520
13.1.13 MODERN LIFE, INC. 521
TABLE 629 MODERN LIFE, INC.: COMPANY OVERVIEW 521
13.1.14 SONDE HEALTH, INC. 522
TABLE 630 SONDE HEALTH, INC.: COMPANY OVERVIEW 522
TABLE 631 SONDE HEALTH, INC.: PRODUCT LAUNCHES 522
TABLE 632 SONDE HEALTH, INC.: DEALS 523
13.1.15 FUTURESTHRIVE 524
TABLE 633 FUTURESTHRIVE: COMPANY OVERVIEW 524
13.1.16 KONINKLIJKE PHILIPS N.V. 525
TABLE 634 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW 525
FIGURE 43 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2022) 526
TABLE 635 KONINKLIJKE PHILIPS N.V.: DEALS 527
13.1.17 ALPHABET INC. (FITBIT) 528
TABLE 636 ALPHABET INC.: COMPANY OVERVIEW 528
FIGURE 44 ALPHABET INC.: COMPANY SNAPSHOT (2022) 529
TABLE 637 ALPHABET INC.: PRODUCT LAUNCHES & APPROVALS 530
TABLE 638 ALPHABET INC.: DEALS 531
13.1.18 RESMED INC. 532
TABLE 639 RESMED INC.: COMPANY OVERVIEW 532
FIGURE 45 RESMED INC.: COMPANY SNAPSHOT (2023) 533
TABLE 640 RESMED INC.: PRODUCT LAUNCHES 534
TABLE 641 RESMED INC.: DEALS 534
13.1.19 APPLE INC. 535
TABLE 642 APPLE INC.: COMPANY OVERVIEW 535
FIGURE 46 APPLE INC.: COMPANY SNAPSHOT (2023) 536
TABLE 643 APPLE INC.: PRODUCT LAUNCHES 537
13.1.20 COGNITIVE HEALTH SOLUTIONS 538
TABLE 644 COGNITIVE HEALTH SOLUTIONS: COMPANY OVERVIEW 538
13.2 OTHER PLAYERS 539
13.2.1 WELLIN5 USA, INC. 539
13.2.2 MOODTOOLS 539
13.2.3 MOODFIT 540
13.2.4 COGNIABLE 540
13.2.5 WOEBOT LABS, INC. 541
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
14 APPENDIX 542
14.1 DISCUSSION GUIDE 542
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 548
14.3 CUSTOMIZATION OPTIONS 550
14.4 RELATED REPORTS 550
14.5 AUTHOR DETAILS 551

*** メンタルヘルススクリーニングの世界市場に関するよくある質問(FAQ) ***

・メンタルヘルススクリーニングの世界市場規模は?
→MarketsandMarkets社は2023年のメンタルヘルススクリーニングの世界市場規模を9億米ドルと推定しています。

・メンタルヘルススクリーニングの世界市場予測は?
→MarketsandMarkets社は2029年のメンタルヘルススクリーニングの世界市場規模を18億米ドルと予測しています。

・メンタルヘルススクリーニング市場の成長率は?
→MarketsandMarkets社はメンタルヘルススクリーニングの世界市場が2023年~2029年に年平均12.2%成長すると展望しています。

・世界のメンタルヘルススクリーニング市場における主要プレイヤーは?
→「Adaptive Testing Technologies(米国)、Proem Behavioral Health(米国)、Aiberry(米国)、SonderMind Inc.(米国)、Clarigent Health(米国)、Riverside Community Care(米国)、Kintsugi Mindful Wellness, Inc.(米国)、Thymia Limited(英国)、Ellipsis Health Inc.(米国)、Canary Speech, Inc. (米国)、Headspace Health社(米国)、Quartet Health社(米国)、Modern Life社(米国)、Sonde Health社(米国)、FuturesTHRIVE社(米国)、Koninklijke Philips N.V.(オランダ)、Alphabet Inc. (Fitbit)(米国)、ResMed(米国)、Apple Inc.(米国)、MoodFit(米国)、Wellin5 USA Inc.(カナダ)、MoodTools(米国)、Cognitive Health Solutions LLC(米国)、Woebot Labs Inc.(米国)、CogniABle(インド)など ...」をメンタルヘルススクリーニング市場のグローバル主要プレイヤーとして判断しています。

※上記FAQの市場規模、市場予測、成長率、主要企業に関する情報は本レポートの概要を作成した時点での情報であり、最終レポートの情報と少し異なる場合があります。

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/



※注目の調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(HIT8966-24 )"メンタルヘルススクリーニングの世界市場予測(~2029):疾患別、スクリーニング別、技術別、年齢別、設定別" (英文:Mental Health Screening Market by Indication (Depression, Bipolar, Schizophrenia, ADHD, Alzheimer, Dementia), Screening (Self, Interview, Observation, Biomarker), Technology (mHealth, Remote Platform, Telehealth), Age, Setting - Global Forecast to 2029)はMarketsandMarkets社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。